WANBURY
Back to Income Statement
|
WANBURY Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹600 Cr | ₹578 Cr | ₹500 Cr | ₹511 Cr | ₹393 Cr |
What is the latest Revenue of WANBURY ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹600 Cr |
| Mar2024 | ₹578 Cr |
| Mar2023 | ₹500 Cr |
| Mar2022 | ₹511 Cr |
| Mar2021 | ₹393 Cr |
How is Revenue of WANBURY Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹600 Cr | 3.77 | |
| Mar2024 | ₹578 Cr | 15.63 | |
| Mar2023 | ₹500 Cr | -2.26 | |
| Mar2022 | ₹511 Cr | 30.23 | |
| Mar2021 | ₹393 Cr | - | |
Compare Revenue of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹796.4 Cr | -4% | -0.7% | -5.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,077.0 Cr | 1.6% | 6% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,324.0 Cr | -0.7% | -1.9% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,235.0 Cr | -0.8% | 7.4% | 21.2% | Stock Analytics | |
| CIPLA | ₹123,294.0 Cr | -0.4% | -3.4% | 0.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,336.0 Cr | 1.2% | 0.3% | -1.5% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -4% |
-0.7% |
-5.2% |
| SENSEX | 0.9% |
2.1% |
8.3% |
You may also like the below Video Courses